ZBHのチャート
ZBHの企業情報
| symbol | ZBH |
|---|---|
| 会社名 | Zimmer Biomet Holdings Inc （ZBH ジンマ―・バイオメット・ホ―ルディングス） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 ジマー・バイオメット・ホールディングス（Zimmer Biomet Holdings Inc.）は整形外科再建製品、スポーツ医学・生物製剤・四肢・外傷用製品、脊椎・骨治癒・頭蓋顎顔面・胸部用製品、歯科インプラント及び関連手術用製品の設計・製造・販売を行う。同社の製品とソリューションは骨・関節・支持軟組織疾患または損傷の患者の治療に使用される。同社は米国及び北・中・南米市場を含む米州、ヨーロッパ、中東及びアフリカ市場を含むEMEA及び日本と他のアジア・太平洋市場を含むアジア太平洋という３つの地域的セグメントを通じて事業を展開する。同社は米州脊椎、骨治癒、頭蓋顎顔面、歯科等の製品種類を有する。 ジンマ―・バイオメット・ホ―ルディングスは米国の医療器具持株会社。主に再建・整形外科用インプラント製品や外科製品を提供する。独自の｢小柱網用金属｣技術を組み込んだ人口関節製品、脊髄インプラント、関節・歯科用のインプラント、整形外科用の各種手術器具、機器を扱う。本社はインディアナ州。 Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products. |
| 本社所在地 | 574 267-6131 |
| 代表者氏名 | Bryan C. Hanson |
| 代表者役職名 | President Chief Executive Officer Director |
| 電話番号 | +1 574-267-6131 |
| 設立年月日 | 36892 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 19000人 |
| url | www.zimmer.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | EBITDA（百万ドル） 2563.40000 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | 時価総額（百万ドル） 26124.81000 |
| 売上高 | 売上高（百万ドル） 7932.90000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 34520.71000 |
| 当期純利益 | 当期純利益（百万ドル） -370.90000 |
| 決算概要 | 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Zimmer Biomet Holdings Inc revenues increased 2% to $7.93B. Net loss before extraordinary items totaled $370.9M vs. income of $541.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net loss reflects Goodwill impairment increase from $304.7M to $975.9M (expense) Selling general and administrative increase of 9% to $3.38B (expense). |
ZBHのテクニカル分析
ZBHのニュース
Zimmer Biomet gains as Evercore ISI upgrades citing Medicare update 2023/04/11 15:21:20 Seeking Alpha
An upgrade from Evercore ISI sent shares of Zimmer Biomet (ZBH) higher Tuesday as the firm pointed to a positive Medicate update. Read the full story here.
Evercore ISI upgrades Zimmer Biomet to Outperform 2023/04/11 12:08:37 Investing.com
https://www.investing.com/news/pro/zimmer-hldgs-receives-investment-bank-analyst-rating-update-3052481
NVIDIA To Rally Around 16%? Here Are 10 Other Analyst Forecasts For Tuesday 2023/04/11 12:03:04 Benzinga
Truist Securities boosted the price target for Murphy Oil Corporation (NYSE: MUR ) from $49 to $56. Truist Securities analyst Neal Dingmann upgraded the stock from Hold to Buy. Murphy Oil shares rose 1% to close at $38.71 on Monday. Evercore ISI Group boosted the price target for Zimmer Biomet Holdings, Inc. (NYSE: ZBH ) from $135 to $148. Evercore ISI Group analyst Vijay Kumar upgraded the stock from In-Line to Outperform. Zimmer Biomet shares rose 0.9% to $129.31 in pre-market trading. Goldman Sachs raised the price target for WW International, Inc. (NASDAQ: WW ) from $3.8 to $13. Goldman Sachs analyst Jason English upgraded the stock from Neutral to Buy. WW International shares fell 1.2% to close at $4.12 on Tuesday. Wells Fargo cut Southwestern Energy Company … Full story available on Benzinga.com
Clarius Group LLC Makes New $202,000 Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) 2023/04/08 17:43:19 EIN News Investing
… and Exchange Commission. The institutional investor bought 1,586 shares of … hedge funds and other institutional investors also recently added to or … . Hedge funds and other institutional investors own 87.21% of the …
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2023 Financial Results 2023/04/04 11:00:00 PR Newswire
WARSAW, Ind., April 4, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its first quarter earnings conference call will be webcast on Tuesday, May 2, 2023 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day…
Congressional Trading Report: Rep. Nicholas V. Taylor Sold Over $100K In Zimmer Biomet Holdings Stock 2022/12/27 15:05:40 Benzinga
Nicholas V. Taylor, a Representative from Texas, reported a sale of Zimmer Biomet Holdings (NYSE: ZBH ) stock on December 26, 2022. According to the Periodic Transaction Report the transaction was placed on December 26, 2022. What Happened: A recent report from the House of Representatives Clerk''s Office on December 26, 2022 reveals that Taylor made a sale of Zimmer Biomet Holdings stock valued between $100,001 - $250,000. Zimmer Biomet Holdings shares are trading up 0.06% at $126.76 at the time of writing. Why Congressional Transactions Matter Congressional transactions shouldn''t be used primarily to make an investing decision, however, … Full story available on Benzinga.com
Thursday Is Your Last Chance To Buy Zimmer Biomet Holdings Before The Dividend Payout 2022/12/20 14:45:35 Benzinga
Thursday marks the last chance for investors to receive the next dividend payout from Zimmer Biomet Holdings (NYSE: ZBH ). What''s Happening The company announced on Thursday that it would pay shareholders a quarterly dividend of 24 cents per share. On Friday, Zimmer Biomet Holdings will go ex-dividend, meaning the stock will trade lower to reflect that payout. … Full story available on Benzinga.com
NeuroOne® to Host Fiscal Fourth Quarter Corporate Update 2022/12/13 21:00:00 Benzinga
EDEN PRAIRIE, Minn. , Dec. 13, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC , ", NeuroOne", or the ", Company", )), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, to host fiscal Fourth Quarter Corporate Update for the period ended September 30, 2022. Fourth Quarter and Recent Business Highlights Received a $3.5 million accelerated payment from distribution partner Zimmer Biomet related to certain milestone events; Zimmer Biomet received a Warrant to purchase 350,000 shares of the Company''s common stock, with an exercise price of $3.00 per share Received FDA 510(k) clearance to market the Evo® sEEG Electrode technology for temporary (less than 30 day) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, enabling NeuroOne to fully address the approximately $100M diagnostic electrode market Shipped initial stocking order to Zimmer Biomet for Evo sEEG Electrodes Completed hardware and software prototypes for preliminary design verification tests on a proprietary radiofrequency (RF) generator for use with the NeuroOne OneRF™ ablation system that is being developed to record brain activity and ablate brain tissue using the same electrode Successfully completed an animal feasibility study with the OneRF combination recording and ablation technology at the Mayo Clinic Successfully tested complete OneRF ablation system with nine leading Neurosurgeons, with encouraging initial feedback Implemented physician advisory board comprised of leading neurosurgeons and pain specialists for our Spinal Cord Stimulation electrode platform Developed electrode designs for spinal cord stimulation to treat chronic back pain CEO Dave Rosa featured on Fox Business Network''s ''Mornings with Maria'' Included in an NIH grant submission with the University of Minnesota to develop a chronic cortical electrode capable of both recording and stimulation, that would, with potential assistance from Medtronic , plug directly into a Medtronic pulse generator.
Syndesmosis Implant Market to Witness Huge Growth by Key Players: Zimmer Biomet, Smith & Nephew, Exactech, Inc, Mortise Medical, Inion Oy 2022/12/06 12:52:45 OpenPR
The Syndesmosis Implant research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive
Zimmer Biomet: Procedural Volumes Normalizing, Rate Buy (NYSE:ZBH) 2022/11/30 23:05:49 Seeking Alpha
Net sales of $1.67Bn tightened by ~90bps YoY, but reported in constant currency terms, was up 500bps from last year. Click for more information.
Syndesmosis Implant Market to Witness Huge Growth by Key Players: Zimmer Biomet, Smith & Nephew, Exactech, Inc, Mortise Medical, Inion Oy 2022/12/06 12:52:45 OpenPR
The Syndesmosis Implant research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive
Zimmer Biomet: Procedural Volumes Normalizing, Rate Buy (NYSE:ZBH) 2022/11/30 23:05:49 Seeking Alpha
Net sales of $1.67Bn tightened by ~90bps YoY, but reported in constant currency terms, was up 500bps from last year. Click for more information.
NeuroOne ships first order of its electrode product to distribution partner Zimmer Biomet 2022/11/30 15:08:24 Seeking Alpha
NeuroOne Medical Technologies (NMTC) on Wednesday said it had shipped the first commercial order to Zimmer Biomet (ZBH) of its Evo sEEG electrode technology for less than 30…
Zimmer Biomet Stock’s Valuation Offset By Lackluster Growth (ZBH) 2022/11/29 17:02:41 Seeking Alpha
Zimmer Biomet''s performance in 2022 has been better than analysts initially expected, but it isn''t really gaining the hoped-for market share. Read more here.
Hand-Held Surgical Instruments Global Market Report 2022: Ukraine-Russia War Impact 2022/11/29 11:48:00 GlobeNewswire
Major players in the hand-held surgical instruments market are Johnson & Johnson, B Braun Melsungen AG, Medtronic, Zimmer Biomet Holdings, KLS MARTIN GROUP, Integra LifeSciences Corporation, Smith & Nephew, Aspen Surgical, CooperSurgical Inc, Thompson Surgical Instruments Inc, Becton Dickinson and Company, Swann-Morton Ltd , Peters Surgical, Huaiyin Medical Instruments CoLtd and CONMED Corporation. Major players in the hand-held surgical instruments market are Johnson & Johnson, B Braun Melsungen AG, Medtronic, Zimmer Biomet Holdings, KLS MARTIN GROUP, Integra LifeSciences Corporation, Smith & Nephew, Aspen Surgical, CooperSurgical Inc, Thompson Surgical Instruments Inc, Becton Dickinson and Company, Swann-Morton Ltd , Peters Surgical, Huaiyin Medical Instruments CoLtd and CONMED Corporation.